Immune cells take on BK virus in vulnerable transplant patients

This study tests whether specially grown immune cells (called cytotoxic T lymphocytes) can safely lower BK virus levels in 20 transplant patients with weakened immune systems. Participants have had a stem cell or kidney transplant and show signs of BK virus infection. The goal is to see if the treatment reduces virus levels and controls symptoms without causing severe side effects.